NCT06449196View on ClinicalTrials.gov

Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living with HIV (PLWH) in Africa

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 27, 2024

Primary Completion Date

February 4, 2025

Study Completion Date

February 4, 2025

Conditions
HIV
Interventions
DRUG

Investigational product HIV Env Mosaic immunogens MOS1SIP, MOS2SIP, M3SIP8 and Monophosphoryl lipid A liposomes (MPLA-5) adjuvant (IM)

HIV Env Mosaic immunogens MOS1SIP, MOS2SIP, M3SIP8 and Monophosphoryl lipid A liposomes (MPLA-5) adjuvant (IM) administered via bolus dosing.

DRUG

: Investigational product HIV Env Mosaic immunogens MOS1SIP, MOS2SIP, M3SIP8 and Monophosphoryl lipid A liposomes (MPLA-5) adjuvant (IM)

HIV Env Mosaic immunogens MOS1SIP, MOS2SIP, M3SIP8 and Monophosphoryl lipid A liposomes (MPLA-5) adjuvant (IM) administered via fractionated dosing

Sponsors

Collaborators (1)

Polymun Scientific GmbH
All Listed Sponsors
collaborator

Polymun Scientific GmbH

INDUSTRY

lead

International AIDS Vaccine Initiative

NETWORK

NCT06449196 - Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living with HIV (PLWH) in Africa | Biotech Hunter | Biotech Hunter